Nintedanib

Nintedanib


Nintedanib is an oral triple angiokinase inhibitor targeting VEGFR, FGFR, and PDGFR pathways to block angiogenesis and suppress tumor growth in cancer and fibrosis research.

Molecular structure of the compound BP-44034
    • Unit
    • Price
    • Qty
    • 5 G
    • $210.00
    • 10 G
    • $380.00
    • 25 G
    • $640.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire